Prevalence of gastric cancer versus colorectal cancer in Asians with a positive fecal occult blood test

  • Lukejohn W. Day
  • John P. Cello
  • Ma Somsouk
  • John M. Inadomi
Original Article



Prior studies have reported conflicting results on the yield of esophagogastroduodenoscopy (EGD) in patients with a positive fecal occult blood test (FOBT). Our aim was to compare the yield between EGD and colonoscopy performed in a racially diverse population with a positive FOBT.


A retrospective, cross-sectional study of FOBT positive patients who underwent EGD and colonoscopy from January 1, 1999 to November 1, 2008. Endoscopic lesions deemed responsible for GI bleeding were identified.


Two hundred and eighty-seven patients met entry criteria, among which, 63% were Asian and 81% were immigrants to the U.S. Forty-four patients had EGD findings deemed responsible for a positive FOBT, the most common being esophagitis (25.0%) and gastric ulceration (15.9%). Forty-two patients had colonoscopic findings likely responsible for a positive FOBT with the most frequent lesion being colonic polyps ≥9 mm in diameter (76.2%). Prevalence of lower and upper GI tract lesions responsible for positive FOBT was similar (14.6% vs. 15.3%, p = 0.2). There was no association between a patient reporting upper GI symptoms, or the presence of anemia and the detection of upper GI tract lesions on endoscopy. Gastric adenocarcinoma (n = 3) was as prevalent as colorectal adenocarcinoma (n = 4). All three patients with gastric adenocarcinomas were Asian (prevalence 1.6%).


In our racially diverse population evaluated for a positive FOBT, gastric adenocarcinoma was as prevalent as colorectal adenocarcinoma; however, gastric adenocarcinoma was limited to Asian patients. EGD and colonoscopy should be considered in the evaluation of patient populations similar to ours, particularly Asian immigrants.


Colonoscopy Colorectal cancer Esophagogastroduodenoscopy Fecal occult blood test Gastric cancer Pancreatobiliary neoplasms Sensitivity Specificity 


  1. 1.
    Rockey DC, Koch J, Cello JP, Sanders LL, McQuaid K. Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests. N Engl J Med. 1998;339:153–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Velez JP, Schwesinger WH, Stauffer J, et al. Bidirectional endoscopy in patients with fecal occult blood. Surg Endosc. 2002;16:117–20.PubMedCrossRefGoogle Scholar
  3. 3.
    Ali M, Yaqub M, Haider Z, Anees I, Bhargava S, Gian J. Yield of dual endoscopy for positive fecal occult blood test. Am J Gastroenterol. 2003;98:82–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Chen YK, Gladden DR, Kestenbaum DJ, Collen MJ. Is there a role for upper gastrointestinal endoscopy in the evaluation of patients with occult blood-positive stool and negative colonoscopy? Am J Gastroenterol. 1993;88:2026–9.PubMedGoogle Scholar
  5. 5.
    Hisamuddin K, Mowat NA, Phull PS. Endoscopic findings in the upper gastrointestinal tract of faecal occult blood-positive, colonoscopy-negative patients. Dig Liver Dis. 2006;38:503–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Rasmussen M, Kronborg O. Upper gastrointestinal cancer in a population-based screening program with fecal occult blood test for colorectal cancer. Scand J Gastroenterol. 2002;37:95–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Zappa M, Visioli CB, Ciatto S, et al. Gastric cancer after positive screening faecal occult blood testing and negative assessment. Dig Liver Dis. 2007;39:321–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Bini EJ, Rajapaksa RC, Valdes MT, Weinshel EH. Is upper gastrointestinal endoscopy indicated in asymptomatic patients with a positive fecal occult blood test and negative colonoscopy? Am J Med. 1999;106:613–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Geller AJ, Kolts BE, Achem SR, Wears R. The high frequency of upper gastrointestinal pathology in patients with fecal occult blood and colon polyps. Am J Gastroenterol. 1993;88:1184–7.PubMedGoogle Scholar
  10. 10.
    McCracken M, Olsen M, Chen Jr MS, et al. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin. 2007;57:190–205.PubMedCrossRefGoogle Scholar
  11. 11.
    Replogle ML, Glaser SL, Hiatt RA, Parsonnet J. Biologic sex as a risk factor for Helicobacter pylori infection in healthy young adults. Am J Epidemiol. 1995;142:856–63.PubMedGoogle Scholar
  12. 12.
    Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000;181:1359–63.PubMedCrossRefGoogle Scholar
  13. 13.
    Zuckerman G, Benitez J. A prospective study of bidirectional endoscopy (colonoscopy and upper endoscopy) in the evaluation of patients with occult gastrointestinal bleeding. Am J Gastroenterol. 1992;87:62–6.PubMedGoogle Scholar
  14. 14.
    Urquhart J, Eisen G, Faigel DO, Mattek N, Holub J, Lieberman DA. A closer look at same-day bidirectional endoscopy. Gastrointest Endosc. 2009;69:271–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Hsia PC, al-Kawas FH. Yield of upper endoscopy in the evaluation of asymptomatic patients with Hemoccult-positive stool after a negative colonoscopy. Am J Gastroenterol. 1992;87:1571–4.PubMedGoogle Scholar
  16. 16.
    Stray N, Weberg R. A prospective study of same day bi-directional endoscopy in the evaluation of patients with occult gastrointestinal bleeding. Scand J Gastroenterol. 2006;41:844–50.PubMedCrossRefGoogle Scholar
  17. 17.
    Leighton JA, Goldstein J, Hirota W, et al. Obscure gastrointestinal bleeding. Gastrointest Endosc. 2003;58:650–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Raju GS, Gerson L, Das A, Lewis B. American Gastroenterological Association (AGA) Institute technical review on obscure gastrointestinal bleeding. Gastroenterology. 2007;133:1697–717.PubMedCrossRefGoogle Scholar
  19. 19.
    Yang L, Parkin DM, Whelan S, et al. Statistics on cancer in China: cancer registration in 2002. Eur J Cancer Prev. 2005;14:329–35.PubMedCrossRefGoogle Scholar
  20. 20.
    Nakama H, Kamijo N, Fattah AS, Zhang B. Immunologic detection of fecal occult blood from upper digestive tract diseases. Hepatogastroenterology. 1998;45:752–4.PubMedGoogle Scholar
  21. 21.
    Nakama H, Kamijo N, Fujimori K, Fattah AS, Zhang B. Diagnostic accuracy of immunochemical faecal occult blood test for gastric cancer. J Med Screen. 1996;3:113–4.PubMedGoogle Scholar
  22. 22.
    Zhou L, Yu H, Zheng S. The value of “occult blood bead” in detection of upper digestive tract disorders with bleeding. Zhonghua Zhong Liu Za Zhi. 1999;21:48–50.PubMedGoogle Scholar
  23. 23.
    Macrae FA, St John DJ, Caligiore P, Taylor LS, Legge JW. Optimal dietary conditions for hemoccult testing. Gastroenterology. 1982;82:899–903.PubMedGoogle Scholar
  24. 24.
    Holman JS, Shwed JA. Influence of sucralfate on the detection of occult blood in simulated gastric fluid by two screening tests. Clin Pharm. 1992;11:625–7.PubMedGoogle Scholar
  25. 25.
    Schentag JJ. False-positive “hemoccult” reaction with cimetidine. N Engl J Med. 1980;303:110.PubMedGoogle Scholar
  26. 26.
    Jaffe RM, Kasten B, Young DS, MacLowry JD. False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med. 1975;83:824–6.PubMedGoogle Scholar
  27. 27.
    Layne EA, Mellow MH, Lipman TO. Insensitivity of guaiac slide tests for detection of blood in gastric juice. Ann Intern Med. 1981;94:774–6.PubMedGoogle Scholar
  28. 28.
    Markman HD. Errors in the guaiac test for occult blood. JAMA. 1967;202:846–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Kato I, Tominaga S, Ito Y, et al. A prospective study of atrophic gastritis and stomach cancer risk. Jpn J Cancer Res. 1992;83:1137–42.PubMedCrossRefGoogle Scholar
  30. 30.
    Barker DJ, Coggon D, Osmond C, Wickham C. Poor housing in childhood and high rates of stomach cancer in England and Wales. Br J Cancer. 1990;61:575–8.PubMedCrossRefGoogle Scholar

Copyright information

© Indian Society of Gastroenterology 2011

Authors and Affiliations

  • Lukejohn W. Day
    • 1
    • 2
    • 4
  • John P. Cello
    • 1
  • Ma Somsouk
    • 1
    • 2
  • John M. Inadomi
    • 3
  1. 1.Division of Gastroenterology, Department of Medicine, San Francisco General HospitalUniversity of CaliforniaSan FranciscoUSA
  2. 2.GI Health Outcomes, Policy and Economics (HOPE) Research Program, Department of MedicineUniversity of CaliforniaSan FranciscoUSA
  3. 3.Department of Medicine, Division of Gastroenterology and HepatologyUniversity of WashingtonSeattleUSA
  4. 4.San Francisco General Hospital (3D-5)San FranciscoUSA

Personalised recommendations